Which prescriptions cause false positives?

Certain prescription medications can contribute to false-positive drug screening results because some compounds share chemical similarities with substances targeted during initial testing. Medications used for attention disorders, pain management, depression, anxiety, sleep disorders, and other medical conditions may occasionally trigger preliminary positive findings on immunoassay screening tests. False positives are generally more associated with initial screening than with confirmatory laboratory analysis.

Amphetamine-based prescription medications used for attention-deficit disorders are one common example because screening tests may react to stimulant-related compounds. Certain opioid medications, antidepressants, benzodiazepines, and sleep medications may also produce screening reactions depending on the substances included in the testing panel. The likelihood of cross-reactivity varies between medications and laboratory testing methods.

Initial screening tests are designed to rapidly identify broad substance classes rather than determine the exact source of exposure. Because of this, chemically related compounds may occasionally trigger positive findings even when the detected substance originated from legitimate prescription use. Screening sensitivity and cutoff thresholds can further influence the likelihood of cross-reactivity.

Confirmatory laboratory testing is commonly used to distinguish prescribed medications from unauthorized substance use. Methods such as gas chromatography and mass spectrometry identify specific compounds and metabolite patterns with substantially greater precision than preliminary screening assays. These techniques significantly reduce the risk of inaccurate final reporting.

Drug testing programs often incorporate medical review procedures when prescription medications may affect results. A medical review officer may evaluate whether documented prescription use explains laboratory findings before reporting outcomes to employers or other entities. Interpretation therefore commonly considers both laboratory data and verified medication history.